PRKD1 and breast cancer: To further define the role of the LPA/PKD-1 signaling pathway in BC progression via ALDH1, we exposed human BC cells to either LPA, an LPA antagonist, or a PKD inhibitor and examined changes in ALDH1A1 expression.